Increase in the number of investors funding AI start-ups, especially for revolutionizing medical diagnostics, is contributing toward AI-based medical diagnostic tools market growth.
AI-powered systems in diagnostics provide precise & efficient diagnosis, thereby letting the healthcare personnel devise adequate and timely treatment plans. Therefore, integration of AI in several diagnostic tools such as X-Rays is incorporated at a larger scale.
The companies operating in AI-based medical diagnostic tools market are working toward devising non-invasive, AI-based diagnostic tools that facilitate precise brain tumor diagnosis.
They are also exploring incorporation of AI-based remote medical devices for elderly nursing care services. Such AI-based clinical insights modules help doctors diagnose the ailments even at distance.
The healthcare vertical is integrating AI-powered solutions in medical diagnostics in order to obtain higher clinical & operational outcomes. Rising incidence of chronic diseases is accelerating the demand for innovative, automated processes.
Dearth of in-person care providers is another factor driving the AI-based diagnostic tools market. As per the WHO, there was a shortage of 4.3 million care providers worldwide in 2019 alone.
The healthcare start-ups are also fast adopting AI-powered systems and receiving funding from the venture capitalists and private investors. For instance, in September 2020, Aidoc received funding of US$ 20 Mn from Peg Capital in a Series B round.
Along the similar lines, in May 2020, Arterys raised investment of US$ 28 Mn in Series C funding, which was led by Temasek Holdings and Bensile Investment Group.
| Attribute | Detail |
|---|---|
| AI-based Medical Diagnostic Tools Market Drivers |
|
Increase in funding for the AI start-ups at the global level are, in turn, raising the demand for incorporating AI into diagnostic imaging modalities. For instance, in March 2022, Qure.ai (Qure) deployed AI for medical imaging diagnostics after raising US$ 40 million through fundraising.
It further declared that it would use this funding for widening and improving its presence in Europe and the U.S. and accelerate development of the products for community diagnostics and critical care.
As per a report published by the Organization for Economic Cooperation and Development (OECD), AI drew 21% share of venture capital investment in the year 2020, reaching US$ 75 billion.
Anthropic, a San Francisco-based, Amazon-backed AI start-up raised US$ 1.3 Bn in 2023. It also invested additional US$ 2.75 billion in March 2024. Microsoft, in the same year, invested US$ 10 Bn in OpenAI, which is the biggest AI deal as of now.
Noticeable funding for AI start-ups is thus contributing toward AI-based medical diagnostic tools market growth.
X-Rays are amongst the most common imaging tests performed in majority of radiology departments. Therefore, potential for AI to help with interpretation of conventional radiographs (X-Ray images) is important. Integrating AI into X-Rays improves their efficiency, precision and workflow, thereby reducing the downtime.
Furthermore, an article entitled ‘These Algorithms Look at X-Rays and Somehow Detect Your Race’ that was published in August 2021 mentioned that the key players are spending heavily on innovations to create an AI software interpreting X-Rays and to identify conditions such as lung tumors. These algorithms can also detect various data points on the scans that clinicians miss to see.
In August 2021, Fujifilm had developed a chest X-Ray program called CXR-AID, which was made available in Japan after obtaining certification from the Pharmaceuticals and Medical Devices Agency (PMDA). This device is able to recognize notably abnormal findings such as pneumothorax and chest nodules from the X-ray images.
Continuous research conducted regarding AI-powered imaging tests is thus driving the AI-based medical diagnostic tools market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest AI-based medical diagnostic tools market analysis, North America dominated the AI-driven diagnostic software landscape in 2023 and the situation is expected to remain the same during the forecast period. This is owing to rise in incidence of cancer all across the U.S.
For instance, the American Cancer Society had published Cancer Facts and Figures in January 2022, which stated that 1.9 million new cases of cancer were registered in 2022. These figures are prompting the healthcare personnel to resort to AI-based diagnostic tools, which fast-track the diagnosis.
As per the Government of Canada’s statistical data released in November 2021, nearly 229,200 Canadians suffered from cancer in 2021 alone, and prostate cancer accounted for 46% of these diagnoses.
Various market players in North America are also engaging in implementation of strategic initiatives, which is contributing to the growth of the AI-based medical diagnostic tools industry.
For instance, in December 021, Roche came up with three AI-based, deep learning image analysis Research Use Only (RUO) algorithms for breast cancer. Additionally, in April 2022, Arterys launched numerous novel modules to its Cardio AI clinical app.
The companies operating in AI-based medical diagnostic tools market are involved in inorganic expansion to broaden their customer base.
For instance, in January 2022, Siemens Healthineers entered into partnership with Ohio State Wexner Medical Center in order to provide cutting-edge imaging and treatment technology to research institutes, Ohio State patient care, and the surrounding regions.
In November 2020, Zebra Medical Vision partnered with Storm ID for developing advanced AI-based algorithms, with the objective of diagnosing osteoporosis. Multiple medical image datasets obtained through AI-based algorithms can be used for precise diagnosis.
Microsoft, Nvidia Corporation, Merative L.P., Alphabet, Inc, Intel Corporation, Siemens Healthineers, GE HealthCare, Advanced Micro Devices, Inc., Koninklijke Philips N.V., and InformAI are some of the key players covered in the AI-based medical diagnostic tools market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.3 Bn |
| Market Forecast (Value) in 2034 | US$ 11.5 Bn |
| Growth Rate (CAGR) | 20.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.3 Bn in 2023
It is projected to advance at a CAGR of 20.8% from 2024 to 2034
Increasing funding for AI start-ups globally and rise in integration of AI into imaging devices
Diagnostics laboratories segment accounted for the largest share in 2023
North America was the dominant region in 2023
Microsoft, Nvidia Corporation, Merative L.P., Alphabet, Inc, Intel Corporation, Siemens Healthineers, GE HealthCare, Advanced Micro Devices, Inc., Koninklijke Philips N.V., and InformAI
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: AI-based Medical Diagnostic Tools Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. AI-based Medical Diagnostic Tools Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global AI-based Medical Diagnostic Tools Market Analysis and Forecast, by Component
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2020-2034
6.3.1. Software
6.3.2. Services
6.3.3. Hardware
6.3.4. Memory
6.3.5. Others (Network, etc.)
6.4. Market Attractiveness Analysis, by Component
7. Global AI-based Medical Diagnostic Tools Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Radiology
7.3.2. Cardiology
7.3.3. Neurology
7.3.4. Oncology
7.3.5. Others (Ophthalmology, Gynecology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global AI-based Medical Diagnostic Tools Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Others (Ambulatory Surgical Centers, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global AI-based Medical Diagnostic Tools Market Analysis and Forecast, by Region
9.1. Introduction
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Region, 2020-2034
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
10. North America AI-based Medical Diagnostic Tools Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2020-2034
10.3.1. Software
10.3.2. Services
10.3.3. Hardware
10.3.4. Memory
10.3.5. Others (Network, etc.)
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Radiology
10.4.2. Cardiology
10.4.3. Neurology
10.4.4. Oncology
10.4.5. Others (Ophthalmology, Gynecology, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Diagnostic Laboratories
10.5.3. Others (Ambulatory Surgical Centers, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe AI-based Medical Diagnostic Tools Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2020-2034
11.3.1. Software
11.3.2. Services
11.3.3. Hardware
11.3.4. Memory
11.3.5. Others (Network, etc.)
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Radiology
11.4.2. Cardiology
11.4.3. Neurology
11.4.4. Oncology
11.4.5. Others (Ophthalmology, Gynecology, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Others (Ambulatory Surgical Centers, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific AI-based Medical Diagnostic Tools Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2020-2034
12.3.1. Software
12.3.2. Services
12.3.3. Hardware
12.3.4. Memory
12.3.5. Others (Network, etc.)
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Radiology
12.4.2. Cardiology
12.4.3. Neurology
12.4.4. Oncology
12.4.5. Others (Ophthalmology, Gynecology, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Others (Ambulatory Surgical Centers, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America AI-based Medical Diagnostic Tools Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2020-2034
13.3.1. Software
13.3.2. Services
13.3.3. Hardware
13.3.4. Memory
13.3.5. Others (Network, etc.)
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Radiology
13.4.2. Cardiology
13.4.3. Neurology
13.4.4. Oncology
13.4.5. Others (Ophthalmology, Gynecology, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Others (Ambulatory Surgical Centers, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa AI-based Medical Diagnostic Tools Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2020-2034
14.3.1. Software
14.3.2. Services
14.3.3. Hardware
14.3.4. Memory
14.3.5. Others (Network, etc.)
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Radiology
14.4.2. Cardiology
14.4.3. Neurology
14.4.4. Oncology
14.4.5. Others (Ophthalmology, Gynecology, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Others (Ambulatory Surgical Centers, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Microsoft
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Nvidia Corporation
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Merative L.P.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Alphabet, Inc
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Intel Corporation
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Siemens Healthineers
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. GE HealthCare
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Advanced Micro Devices, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. InformAI
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 02: Global AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 03: Global AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 07: North America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 08: North America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 11: Europe AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 12: Europe AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 15: Asia Pacific AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 19: Latin America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 20: Latin America AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Component, 2020-2034
Table 23: Middle East & Africa AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global AI-based Medical Diagnostic Tools Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global AI-based Medical Diagnostic Tools Market Revenue (US$ Bn), by Component, 2023
Figure 03: Global AI-based Medical Diagnostic Tools Market Value Share, by Component, 2023
Figure 04: Global AI-based Medical Diagnostic Tools Market Revenue (US$ Bn), by Application, 2023
Figure 05: Global AI-based Medical Diagnostic Tools Market Value Share, by Application, 2023
Figure 06: Global AI-based Medical Diagnostic Tools Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global AI-based Medical Diagnostic Tools Market Value Share, by End-user, 2023
Figure 08: Global AI-based Medical Diagnostic Tools Market Value Share, by Region, 2023
Figure 09: Global AI-based Medical Diagnostic Tools Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 11: Global AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global AI-based Medical Diagnostic Tools Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America AI-based Medical Diagnostic Tools Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 22: North America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 26:North America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe AI-based Medical Diagnostic Tools Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe AI-based Medical Diagnostic Tools Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 31: Europe AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific AI-based Medical Diagnostic Tools Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific AI-based Medical Diagnostic Tools Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 40: Asia Pacific AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America AI-based Medical Diagnostic Tools Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 49: Latin America AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa AI-based Medical Diagnostic Tools Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa AI-based Medical Diagnostic Tools Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa AI-based Medical Diagnostic Tools Market Value Share Analysis, by Component, 2023 and 2034
Figure 58: Middle East & Africa AI-based Medical Diagnostic Tools Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa AI-based Medical Diagnostic Tools Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa AI-based Medical Diagnostic Tools Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
AI-based Medical Diagnostic Tools Market
